Clinical Trials · NCT02321878
Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,092
- Start date
- Dec 2014
- Locations
- 5 sites, Japan
- Primary endpoint
- Number of AEs (adverse events)